Biomarker Assay Testing – Olink Explorer Platform

The contract involves the execution of high-throughput protein profiling using the Olink Explorer platform on human biospecimens to support neurodegenerative disease research. This includes end-to-end sample processing, stringent quality control measures, and data harmonization to ensure consistency and reliability across datasets. The service provider is expected to handle biological samples with precision, adhere to validated protocols for protein detection, and deliver analytically robust data that can be integrated into broader research initiatives focused on identifying and validating biomarkers for neurodegenerative conditions. The contract is classified as a subcontract under NAICS code 541380, which pertains to other scientific research and development services. It is issued by the Department of Veterans Affairs through Rpo East (36C24E), with a response deadline of August 3, 2026. The work is to be performed at an unspecified location, and there is no set-aside designation or specific geographic requirement outlined. The focus is on technical execution, data integrity, and alignment with research goals related to neurodegeneration, requiring experience with Olink technology and proficiency in handling clinical biospecimens under rigorous standards.